Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
Investing in Malaysia's largest clinic operator to expand the healthcare business
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents
A game changing solution for the pharmaceutical industry
The company plans to add 1700 beds by FY27 through the organic route
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Subscribe To Our Newsletter & Stay Updated